CA2306452A1 - Use of growth differentiation factor-9 (gdf-9) as a contraceptive - Google Patents

Use of growth differentiation factor-9 (gdf-9) as a contraceptive Download PDF

Info

Publication number
CA2306452A1
CA2306452A1 CA002306452A CA2306452A CA2306452A1 CA 2306452 A1 CA2306452 A1 CA 2306452A1 CA 002306452 A CA002306452 A CA 002306452A CA 2306452 A CA2306452 A CA 2306452A CA 2306452 A1 CA2306452 A1 CA 2306452A1
Authority
CA
Canada
Prior art keywords
gdf
leu
ser
pro
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002306452A
Other languages
English (en)
French (fr)
Inventor
Se-Jin Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2306452A1 publication Critical patent/CA2306452A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/495Transforming growth factor [TGF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0006Contraceptive vaccins; Vaccines against sex hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002306452A 1997-10-06 1998-10-06 Use of growth differentiation factor-9 (gdf-9) as a contraceptive Abandoned CA2306452A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/946,092 1997-10-06
US08/946,092 US6030617A (en) 1993-01-12 1997-10-06 Use of growth differentiation factor-9 (GDF-9) to inhibit oocyte maturation
PCT/US1998/021199 WO1999017797A1 (en) 1997-10-06 1998-10-06 Use of growth differenciation factor-9 (gdf-9) as a contraceptive

Publications (1)

Publication Number Publication Date
CA2306452A1 true CA2306452A1 (en) 1999-04-15

Family

ID=25483945

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002306452A Abandoned CA2306452A1 (en) 1997-10-06 1998-10-06 Use of growth differentiation factor-9 (gdf-9) as a contraceptive

Country Status (6)

Country Link
US (1) US6030617A (enExample)
EP (1) EP1021201A4 (enExample)
JP (1) JP2001518516A (enExample)
AU (1) AU757563B2 (enExample)
CA (1) CA2306452A1 (enExample)
WO (1) WO1999017797A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4676600A (en) * 1999-04-30 2000-11-17 Curis, Inc. Morphogen-induced enhancement of fertility
NZ502796A (en) * 2000-06-15 2003-02-28 Agres Ltd Nucleotide and amino acid sequences of oocyte factors related to GDF-9B or GDF-9
NZ519330A (en) * 2002-05-30 2004-12-24 George Henry Davis New sequences for altering mammalian ovarian function and ovulation rate
JP2008521891A (ja) * 2004-12-02 2008-06-26 アグリサーチ・リミテッド 排卵の調節
EP2228070B1 (en) 2005-07-18 2016-09-07 Adelaide Research & Innovation Pty Ltd Modulation of granulosa cell apoptosis
CN101410132A (zh) * 2006-03-28 2009-04-15 惠氏公司 用于治疗骨疾病的gdf-9/bmp-15调节剂
CA3058678A1 (en) * 2017-02-01 2018-08-09 Newsouth Innovations Pty Limited Gamete-secreted growth factors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994015966A1 (en) * 1993-01-12 1994-07-21 Johns Hopkins University School Of Medicine Growth differentiation factor-9
CA2171546A1 (en) * 1993-10-08 1995-04-20 Se-Jin Lee Growth differentiation factor-10
US5688506A (en) * 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone

Also Published As

Publication number Publication date
AU1071499A (en) 1999-04-27
AU757563B2 (en) 2003-02-27
US6030617A (en) 2000-02-29
JP2001518516A (ja) 2001-10-16
WO1999017797A1 (en) 1999-04-15
EP1021201A4 (en) 2004-09-15
EP1021201A1 (en) 2000-07-26

Similar Documents

Publication Publication Date Title
US6365402B1 (en) Growth differentiation factor-9
US6420543B1 (en) Growth differentiation factor-15
US5827733A (en) Growth differentiation factor-8 (GDF-8) and polynucleotides encoding same
AU697625B2 (en) Growth differentiation factor-6
CA2194660C (en) Growth differentiation factor-11
US6204047B1 (en) Growth differentiation factor-10
US6245896B1 (en) Antibodies that binds growth differentiation factor 5
US6680372B1 (en) Antibodies specific for growth differentiation factor-7
EP1475440A2 (en) Growth differentiation factor-3
US6524802B1 (en) Methods of detecting growth differentiation factor-14
US6191261B1 (en) Growth differentiation factor-9 antibodies and methods
US6428966B1 (en) Growth differentiation factor, lefty-1
US6635480B1 (en) Growth differentiation factor, lefty-2
AU757563B2 (en) Use of growth differenciation factor-9 (GDF-9) as a contraceptive
US6391565B2 (en) Methods of detecting growth differentiation factor-3
US7098323B1 (en) Growth differentiation factor-16
US6713302B1 (en) Growth differentiation factor-6
US20040043025A1 (en) Growth differentiation factor-12
US20020107369A1 (en) Growth differentiation factor-10
HK1072781A (en) Growth differentiation factor-3

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued